header logo image


Page 22«..10..19202122

Archive for the ‘Neuropathy’ Category

Neuropathy: Symptoms, Causes, Types, Treatment, Nutrition …

Monday, October 1st, 2018

Medication can help relieve pain symptoms, as well as improve sleep and quality of life, but it wont reverse or cure neuropathy, Dr. Williams says.

Common over-the-counter medication that people reach for to address mild to moderate neuropathic pain includesTylenol (acetaminophen),nonsteroidal inflammatory drugs (NSAIDs)such as Advil (ibuprofen) and Aleve (naproxen),and topical treatments such as capsaicin and lidocaine creams. Prescription medication such as COX-2 inhibitors likeCelebrex (celecoxib), opioids, and Ultram (tramadol) can be taken as well. (22)

Patients can get a measure of relief from such traditional, nonspecific medication, he says. But they are more likely to gain relief from certain categories of medication that have a specific effect on the pain pathways. They act on pain from abnormal nerve firing or nerve signals.

Williams says antidepressant, antiseizure, and antiepileptic medications are the types of categories were likely to turn to and can be most helpful.

Antidepressants have an effect on some of the neurotransmitters like norepinephrine and serotonin, which can have an effect on pain, he explains. Among the options in this category of treatment are selective serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine) and Zoloft (sertraline), which restore the chemical balance in the nerve cells of the brain; serotonin and norepinephrine reuptake inhibitors (SNRIs), such as Cymbalta (duloxetine) and Effexor (venlafaxine), which inhibit the production and release of specific neurotransmitters, including serotonin and norepinephrine; norepinephrine reuptake inhibitors (NRIs), which inhibit the reuse of the neurotransmitters dopamine, serotonin, and norepinephrine; and serotonin receptor modulators, such as Oleptro (trazodone), which increase the levels of serotonin and norepinephrine in the brain available to transmit signals to other nerves.

Williams says the effectiveness of anticonvulsants is still being investigated, but we believe the mechanism of effect is on calcium channels, and that can reduce transmission of those abnormal nerve signals, often within the peripheral nerve or the spinal cord. Gabapentin is an example of an anticonvulsant thats used to relieve nerve pain in people who have had shingles or have diabetes. (23,24)

There are other treatments that act more directly on nerves, such as neuromodulation or surgery. Neuromodulation can involve placing an electrode along a peripheral nerve. These are helpful by essentially turning off pain signals, explains Williams. You can do that very selectively with individual peripheral nerves or you can take a more regional approach with spinal cord stimulation.

Surgery can be useful to release pressure on a nerve, says Peter Highlander, DPM, a podiatrist based in Sandusky, Ohio.Its a technique more commonly used to treat the pain of carpal tunnel syndrome, but it can also be used to treat diabetic neuropathy. (25,26)

Learn More About Neuropathy Treatment Options

Here is the original post:

Neuropathy: Symptoms, Causes, Types, Treatment, Nutrition ...

Read More...

10 Symptoms of Neuropathy – Bodily Numbness and Tingling

Monday, October 1st, 2018

Neuropathy, medically referred to as peripheral neuropathy or PN, signifies a problem with the functionality of the peripheral nerves. These nerves are responsible for transmission of signals from the central nervous system to the rest of the body. Depending upon which type of peripheral nerve is affected, PN may produce a wide variety of symptoms with varying degrees of severity. In a lot of cases, other health conditions perpetuate PN, and thus, it can be both a symptom and disease unto itself. Here is a list of symptoms that may signal the onset of peripheral neuropathy. If they occur, getting tested for PN would be wise.

If peripheral neuropathy affects the sensory nerves in an individual, it is likely that they may experience numbness andtingling in localized areas of the body. This occurs because the nerves that carry messages of sensationi.e., touch, pain, temperature, etc.are not performing optimally. Numbness generally occurs in the lower half of the body with an increasing loss of perception of stimuli in the region. Tingling signifies a kind of mild, prickly feeling of localized magnitude.

Follow this link:

10 Symptoms of Neuropathy - Bodily Numbness and Tingling

Read More...

Peripheral neuropathy – Diagnosis and treatment – Mayo Clinic

Monday, October 1st, 2018

Diagnosis

Peripheral neuropathy has many potential causes. Besides a physical exam, which may include blood tests, diagnosis usually requires:

Your doctor may order tests, including:

Treatment goals are to manage the condition causing your neuropathy and to relieve symptoms. If your lab tests indicate no underlying condition, your doctor might recommend watchful waiting to see if your neuropathy improves.

Besides medications used to treat conditions associated with peripheral neuropathy, medications used to relieve peripheral neuropathy signs and symptoms include:

Pain relievers. Over-the-counter pain medications, such as nonsteroidal anti-inflammatory drugs, can relieve mild symptoms. For more-severe symptoms, your doctor might prescribe painkillers.

Medications containing opioids, such as tramadol (Conzip, Ultram) or oxycodone (Oxycontin, Roxicodone, others), can lead to dependence and addiction, so these drugs generally are prescribed only when other treatments fail.

Topical treatments. Capsaicin cream, which contains a substance found in hot peppers, can cause modest improvements in peripheral neuropathy symptoms. You might have skin burning and irritation where you apply the cream, but this usually lessens over time. Some people, however, can't tolerate it.

Lidocaine patches are another treatment you apply to your skin that might offer pain relief. Side effects can include drowsiness, dizziness and numbness at the site of the patch.

Antidepressants. Certain tricyclic antidepressants, such as amitriptyline, doxepin and nortriptyline (Pamelor), have been found to help relieve pain by interfering with chemical processes in your brain and spinal cord that cause you to feel pain.

The serotonin and norepinephrine reuptake inhibitor duloxetine (Cymbalta) and the extended-release antidepressant venlafaxine (Effexor XR) also might ease the pain of peripheral neuropathy caused by diabetes. Side effects may include dry mouth, nausea, drowsiness, dizziness, decreased appetite and constipation.

Various therapies and procedures might help ease the signs and symptoms of peripheral neuropathy.

Plasma exchange and intravenous immune globulin. These procedures, which help suppress immune system activity, might benefit people with certain inflammatory conditions.

Plasma exchange involves removing your blood, then removing antibodies and other proteins from the blood and returning the blood to your body. In immune globulin therapy, you receive high levels of proteins that work as antibodies (immunoglobulins).

Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this disease.

To help you manage peripheral neuropathy:

Some people with peripheral neuropathy try complementary treatments for relief. Although researchers haven't studied these techniques as thoroughly as they have most medications, the following therapies have shown some promise:

You're likely to start by seeing your primary care provider. You may then be referred to a doctor trained in nervous system disorders (neurologist).

Here's information to help you prepare for your appointment.

When you make the appointment, ask if there's anything you need to do in advance, such as fasting for a specific test. Make a list of:

Take a family member or friend along, if possible, to help you remember the information you're given.

For peripheral neuropathy, basic questions to ask your doctor include:

Don't hesitate to ask other questions.

Your doctor is likely to ask you questions, such as:

Aug. 09, 2017

See the rest here:

Peripheral neuropathy - Diagnosis and treatment - Mayo Clinic

Read More...

List of Peripheral Neuropathy Medications (11 Compared …

Monday, October 1st, 2018

Other names: Neuropathy

About Peripheral Neuropathy: Peripheral neuropathy is failure of the nerves that carry information to and from the brain and spinal cord. This produces symptoms like pain, loss of sensation, and inability to control muscles.

See also: sub-topics

The following list of medications are in some way related to, or used in the treatment of this condition.

6.0

Generic name:gabapentin systemic

Drug class: gamma-aminobutyric acid analogs

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

6.0

Generic name:levocarnitine systemic

Brand names: L-Carnitine, Carnitor, Carnitor SF

Drug class: nutraceutical products

For consumers: dosage, interactions,

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

6.0

Generic name:duloxetine systemic

Drug class: serotonin-norepinephrine reuptake inhibitors

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

6.0

Generic name:carbamazepine systemic

Drug class: dibenzazepine anticonvulsants

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

7.0

Generic name:levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

Off Label: Yes

7.0

Generic name:capsaicin topical

Brand name: Qutenza

Drug class: miscellaneous topical agents

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts

Off Label: Yes

7.0

Generic name:pregabalin systemic

Drug class: gamma-aminobutyric acid analogs

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph

Off Label: Yes

5.0

Generic name:capsaicin topical

Drug class: miscellaneous topical agents

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

Generic name:levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

For professionals: AHFS DI Monograph, Prescribing Information

Off Label: Yes

1.0

Generic name:phenytoin systemic

Drug class: hydantoin anticonvulsants, group I antiarrhythmics

For consumers: dosage, interactions,

For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

Off Label: Yes

4.0

Generic name:levocarnitine systemic

Drug class: nutraceutical products

For consumers: dosage, interactions, side effects

For professionals: Prescribing Information

Off Label: Yes

The following products are considered to be alternative treatments or natural remedies for Peripheral Neuropathy. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Peripheral Neuropathy.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Link:

List of Peripheral Neuropathy Medications (11 Compared ...

Read More...

Neuropathy – Lab Tests Online

Monday, October 1st, 2018

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests OnlineEditorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used. To access online sources, copy and paste the URL into your browser.

Sources Used in Current Review

National Institute of Neurological Disorders and Stroke (December 2014). Peripheral Neuropathy Fact Sheet. Available online at http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm. Accessed May 19, 2016.

The Foundation for Peripheral Neuropathy. Available online at https://www.foundationforpn.org. Accessed May 19, 2016.

Mayo Clinic (20 May 2016 updated). Peripheral Neuropathy. Available online at http://www.mayoclinic.org/diseases-conditions/peripheral-neuropathy/home/ovc-20204944. Accessed May 20, 2016.

Azhary H, Farooq MU, Bhanushali M, et al. Peripheral Neuropathy: Differential Diagnosis and Management. American Family Physician. 2010;81 (7):887-892.

Quest Diagnostics. Laboratory Diagnosis of Peripheral Neuropathy. Available online at http://www.questdiagnostics.com/testcenter/testguide.action?dc=WP_LabDiagnosis_PeripheralNeurop. Accessed November 2016.

Mikhael, Joseph. A Diagnostic Approach to Patients with an IgM Monoclonal Protein. The Hematologist. September-October 2014, Volume 11, Issue 5. Available online at http://www.hematology.org/Thehematologist/Ask/3186.aspx. Accessed November 2016.

Ramchandren S1, Lewis RA. An update on monoclonal gammopathy and neuropathy. Curr Neurol Neurosci Rep. 2012 Feb;12(1):102-10. Available online at https://www.ncbi.nlm.nih.gov/pubmed/22090258. Accessed November 2016.

Sources Used in Previous Reviews

Dugdale, D. (Updated 2010 August 27). Peripheral neuropathy. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000593.htm. Accessed May 2011.

(2010 April 21). Peripheral Neuropathy. JAMA Patient Page v 303 (15) [On-line information]. PDF available for download at http://jama.ama-assn.org/content/303/15/1556.full.pdf. Accessed May 2011.

(Updated 2011 February 18) Peripheral Neuropathy Fact Sheet. National Institute of Neurological Disorders and Stroke [On-line information]. Available online at http://www.ninds.nih.gov/disorders/peripheralneuropathy/detail_peripheralneuropathy.htm. Accessed May 2011.

Lin, H. (Updated 2011 May 13). Diabetic Neuropathy. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/1170337-overview. Accessed May 2011.

Sewell, A. (Updated 2010 September 27). Nutritional Neuropathy. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/1171558-overview. Accessed May 2011.

Hill, H and Tebo, A. (Updated 2011 April). Neuropathic Disease. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/NeuropathicDz.html?client_ID=LTD. Accessed May 2011.

(2009 February). Diabetic Neuropathies: The Nerve Damage of Diabetes National Diabetes Information Clearinghouse [On-line information]. Available online at http://diabetes.niddk.nih.gov/dm/pubs/neuropathies/. Accessed May 2011.

Mayo Clinic Staff (2009 November 3). Peripheral Neuropathy. MayoClinic.com [On-line information]. Available online at http://www.mayoclinic.com/health/peripheral-neuropathy/DS00131/METHOD=print. Accessed May 2011.

Mayo Clinic Staff (2010 April 15). Autonomic Neuropathy. MayoClinic.com [On-line information]. Available online at http://www.mayoclinic.com/health/autonomic-neuropathy/DS00544/METHOD=print. Accessed May 2011.

(Updated 2011 March 22). Giant Axonal Neuropathy. National Institute of Neurological Disorders and Stroke [On-line information]. Available online at http://www.ninds.nih.gov/disorders/gan/GiantAxonalNeuropathy.htm. Accessed May 2011.

(Updated 2011 February 15). Charcot-Marie-Tooth Disease Fact Sheet. National Institute of Neurological Disorders and Stroke [On-line information]. Available online at http://www.ninds.nih.gov/disorders/charcot_marie_tooth/detail_charcot_marie_tooth.htm. Accessed May 2011.

Dugdale, D. (Updated 2010 August 27). Alcoholic neuropathy. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000714.htm. Accessed May 2011.

Eckman, A. (Updated 2010 April 19). Diabetic neuropathy. MedlinePlus Medical Encyclopedia [On-line information]. Available online at http://www.nlm.nih.gov/medlineplus/ency/article/000693.htm. Accessed May 2011.

Rubin, M. (Revised 2008 February). Peripheral Neuropathy. Merck Manual for Healthcare Professionals [On-line information]. Available online at http://www.merckmanuals.com/professional/sec16/ch223/ch223h.html?qt=neuropathy&alt=sh. Accessed May 2011. [On-line information]. Available online at

Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds, (2005) Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 2500-2509, 2510-2514.

What is Neuropathy? Neuropathy Causes and Treatments. Medical News Today. Article date 29 Apr 2009.Available online at http://www.medicalnewstoday.com/articles/147963.php.Accessed August 2011.

ARUP Lab Tests. Motor Neuropathy Panel. Available online at http://www.aruplab.com/guides/ug/tests/0051225.jsp.Accessed August 2011.

Mayo Clinic. 57234 Clinical: Motor Neuropathy Antibody Panel (Serum). Available online at http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/57234.Accessed August 2011.

ARUP Lab Tests. Sensory Neuropathy Antibody Panel with Reflex to PCCA Titer, ANNA Titer & Neuronal Immunoblot. Available online at http://www.aruplab.com/guides/ug/tests/0051222.jsp.Accessed August 2011.

Quest Diagnostics. Motor and Sensory Neuropathy Panel. Available online at http://www.questdiagnostics.com/hcp/testmenu/jsp/showTestMenu.jsp?s=M&test_code=95775&fn=17540X.html&labCode=SJC.Accessed August 2011.

Nervous System Information. Body Guide, Powered by ADAM. Available online at http://www.pennmedicine.org/health_info/body_guide/reftext/html/nerv_sys_fin.html. Accessed August 2011.

Neuropathic Pain. Weill Cornell Pain Medical College. Available online at http://www.cornellpainmedicine.com/health_library/neuropathic_pain.html. Accessed August 2011.

Dr. Wayne Moore,Neuropathologist.Vancouver General Hospital Associate Professor,Dept. of Pathology & Laboratory Medicine,The University of British Columbia Vancouver, Canada.

Read more:

Neuropathy - Lab Tests Online

Read More...

Neuropathy | Cleveland Clinic

Monday, October 1st, 2018

What is neuropathy?

Neuropathy also called peripheral neuropathy refers to any condition that affects the normal activity of the nerves of the peripheral nervous system. The peripheral nervous system is the network of nerves that connects the central nervous system the brain and spinal cord to the rest of the body.

The peripheral nervous system is made up of 3 types of nerves, each with an important role to play in keeping your body healthy and functioning properly.

Neuropathy results when nerve cells, or neurons, are damaged or destroyed. This distorts the way the neurons communicate with each other and with the brain. Neuropathy can affect 1 nerve or nerve type, or a combination of nerves.

Neuropathy is very common. It is estimated that about 25% to 30% of Americans will be affected by neuropathy. Neuropathy occurs in 60% to 70% of people with diabetes.

Neuropathy affects people of all ages; however, older people are at increased risk. It is more common in men and in Caucasians. People in certain professions, such as those that require repetitive motions, have a greater chance of developing compression-related neuropathy.

There are many causes of neuropathy. The cause can be hereditary (runs in families) or acquired (develops after birth).

The most common hereditary neuropathy is Charcot-Marie-Tooth (CMT) disease, which affects both motor and sensory nerves. CMT affects about one in 2,500 people in the United States. CMT causes weakness in the foot and lower leg muscles. Deformities of the feet are also common, making it difficult to walk and often resulting in falls. In its later stages, CMT can also affect the muscles in the hands. There is no cure for hereditary neuropathy.

Acquired neuropathy is much more common. There are many causes of acquired neuropathy, including:

When the cause of the neuropathy cannot be determined, it is called idiopathic neuropathy. About 30 to 40% of neuropathy cases are idiopathic. Another 30% are the result of diabetes.

Symptoms of neuropathy vary depending on the type and location of the nerves involved. Symptoms can appear suddenly, which is called acute neuropathy, or develop slowly over time, called chronic neuropathy.

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

See more here:

Neuropathy | Cleveland Clinic

Read More...

What Is Peripheral Neuropathy? | Living With Peripheral …

Monday, October 1st, 2018

Peripheral neuropathy is not a single disease. Its a general term for a series of disorders that result from damage to the bodys peripheral nervous system.

The bodys nervous system is made up of two parts. The central nervous system (CNS) includes the brain and the spinal cord. The peripheral nervous system (PNS) connects the nerves running from the brain and spinal cord to the rest of the bodythe arms and hands, legs and feet, internal organs, joints and even the mouth, eyes, ears, nose, and skin.

Peripheral neuropathy occurs when nerves are damaged or destroyed and cant send messages from the brain and spinal cord to the muscles, skin and other parts of the body.

Peripheral nerves go from the brain and spinal cord to the arms, hands, legs, and feet. When damage occurs, numbness and pain in these areas may occur.

Peripheral neuropathy can affect multiple nerves (polyneuropathy) or only one nerve or nerve group (mononeuropathy) at a time.

Mononeuropathy is usually the result of damage to a single nerve or nerve group by trauma, injury, local compression, prolonged pressure, or inflammation.

Examples include:

The majority of people, however, suffer from polyneuropathy, an umbrella term for damage involving many nerves at the same time.

More:

What Is Peripheral Neuropathy? | Living With Peripheral ...

Read More...

Neuropathy, Cancer, Information, Resources | CancerCare

Monday, October 1st, 2018

Lymph nodes are small, bean-shaped masses of tissue that are located in clusters throughout the body, including in the armpit. Lymph nodes play a crucial role in helping to fight infection; they filter and trap bacteria, viruses, and other unwanted substances in the body, so that special white blood cells (called lymphocytes) can then destroy them.

When treating cancer, doctors sometimes choose to remove and biopsy nearby lymph nodes to learn whether any of the nodes contain cancer cells. This information helps determine whether the cancer has spread to other parts of the body, a process known as staging. This information also helps the health care team decide on an appropriate and tailored treatment plan.

As with any surgical procedure, there might be side effects. You may sustain some degree of nerve damage during the procedure, resulting in tingling, numbness, or weakness in your arm. These neuropathy symptoms can be mild or more severe, depending on the extent of nerve involvement. You may experience swelling in the arm due to a build-up of lymph fluid that is no longer draining effectively through the remaining lymph nodes; this condition is called lymphedema. You may experience a temporary inflammation of blood vessels in your armpit as well as a higher potential for blood clotting and infection at the biopsy site.

If your health care team has recommended this procedure for you, it is likely because they feel that the benefits outweigh any of these potential risks. Nevertheless, it is always a good idea to have a frank discussion with your surgeon about possible side effects and any preventive measures you can take to lower your risk of experiencing them.

We offer resources about lymphedema and neuropathy.

For more information about lymphedema, please visit The National Lymphedema Network.

To learn more about lymph node removal surgery, please visit The National Cancer Institute.

Continue reading here:

Neuropathy, Cancer, Information, Resources | CancerCare

Read More...

What is Neuropathy? | Neuropathy Support Network

Monday, October 1st, 2018

by Waden E. Emery III MD FAAN, Neuromuscular NeurologistBoard Certified in Neurology, Asst Clinical Professor in NeurologyMiller School of Medicine University of Miami

Your nervous system consists of two primary systems, the Peripheral Nervous System and the Central Nervous System.

The Central Nervous System is made up of the brain and spinal cord.

The Peripheral Nervous System is the largest nervous system of the human body running throughoutyour entire body except foryour brain andyour spinal cord, and is separated into two distinct systems, the Somatic Nervous System and the Autonomic Nervous System.

Autonomic Neuropathy is a Peripheral Neuropathy. That is to say every person that has Autonomic Neuropathy has Peripheral Neuropathy, but everyone that has Peripheral Neuropathymay or maynot have Autonomic Neuropathy.

Peripheral Neuropathyusually affects the hands and feet, causing weakness, numbness, tingling and pain. It can also result in trouble with balance and walking, as well as in problems with grasping items, such as a coffee cup or salt shaker. Peripheral Neuropathys course is variable; it can come and go, slowly progressing over many years, or it can become severe and debilitating. However, if diagnosed early, Peripheral Neuropathy can often be controlled.

Human Nerve Cell

Neuropathy is a result of damage to the nerves most often found in the Peripheral Nervous Systemthat controlsthe motor, sensory, or autonomic nerves required to transmit voluntary and involuntary messages to the brain. Neuropathy can affect or damage the axon (actual nerve), and/or the myelin (covering of the nerves which assists in the transmission signals). Neuropathy can alsoaffect or damage the small and/or large fiber nerves. Small Fiber Neuropathy can now be diagnosed with a simple skin biopsy.

Living with Autonomic Neuropathy In looking at the various components of the autonomic nervous system which can be affected by autonomic neuropathy, these authorities note that it can and does affect the urinary, the cardiac (heart beat), digestive, pulmonary (breathing) systems, it also affects the bodys ability to regulate temperature, tearing, sexual functions, blood pressure, saliva production, swallowing among other body systems that function automaticallyREAD MORE

Small Fiber Neuropathy So many neuropathy patients have heard these words from very qualified neurologists and health professionals. Your EMG and Nerve Conduct Studies are normal. You do not have neuropathy not so quick. Dr. Norman Latov of Cornell University states that the EMG and Nerve Conduct Studies only measure damage toREAD MORE

Diabetic Neuropathy According to the experts, diabetic neuropathy is the most common cause of about 50% of all neuropathies. Dr. Todd Levine recently participated in a Facebook chat on the subject of Understanding Pre-Diabetes, Diabetes, and Diabetic Neuropathy. Some doctors deny the existence of neuropathy from pre-diabetes but see the following two references: 1. Norman Latov, MDREAD MORE

Celiac Disease and Neuropathy Dr. Howard Sanders published an article on The Link Between Celiac Disease and Neuropathy and was featured on The Neuropathy Associations website before they closed on Dec 31, 2014 and brings attention to the need for some patients presenting with neuropathy and the symptoms of Celiac Disease to be tested. Howard. W. Sander, M.D. is aREAD MORE

Medication Induced Neuropathy Peter D. Donofrio, M.D. is professor of Neurology and director of the Neuromuscular Division of the Department of Neurology at Vanderbilt University Medical Center. He is director of Neuropathy Center at Vanderbilt. To read his excellent article on Medication Induced Neuropathy and insights on the LIMITS of the blood-brain barrier a concept which was often misused byREAD MORE

Continue reading here:

What is Neuropathy? | Neuropathy Support Network

Read More...

Peripheral neuropathy – Wikipedia

Monday, October 1st, 2018

Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected. Common causes include toxic exposure such as Agent Orange, systemic diseases (such as diabetes or leprosy), hyperglycemia-induced glycation,[1][2][3] vitamin deficiency, medication (e.g., chemotherapy, or commonly prescribed antibiotics including metronidazole and the fluoroquinolone class of antibiotics (Ciprofloxacin, Levaquin, Avelox etc.)), traumatic injury, including ischemia, radiation therapy, excessive alcohol consumption, immune system disease, coeliac disease, or viral infection. It can also be genetic (present from birth) or idiopathic (no known cause).[4][5][6] In conventional medical usage, the word neuropathy (neuro-, "nervous system" and -pathy, "disease of")[7] without modifier usually means peripheral neuropathy.

Neuropathy affecting just one nerve is called "mononeuropathy" and neuropathy involving nerves in roughly the same areas on both sides of the body is called "symmetrical polyneuropathy" or simply "polyneuropathy". When two or more (typically just a few, but sometimes many) separate nerves in disparate areas of the body are affected it is called "mononeuritis multiplex", "multifocal mononeuropathy", or "multiple mononeuropathy".[4][5][6]

Peripheral neuropathy may be chronic (a long-term condition where symptoms begin subtly and progress slowly) or acute (sudden onset, rapid progress, and slow resolution). Acute neuropathies demand urgent diagnosis. Motor nerves (that control muscles), sensory nerves, or autonomic nerves (that control automatic functions such as heart rate, body temperature, and breathing) may be affected. More than one type of nerve may be affected at the same time. Peripheral neuropathies may be classified according to the type of nerve predominantly involved, or by the underlying cause.[4][5][6]

Neuropathy may cause painful cramps, fasciculations (fine muscle twitching), muscle loss, bone degeneration, and changes in the skin, hair, and nails. Additionally, motor neuropathy may cause impaired balance and coordination or, most commonly, muscle weakness; sensory neuropathy may cause numbness to touch and vibration, reduced position sense causing poorer coordination and balance, reduced sensitivity to temperature change and pain, spontaneous tingling or burning pain, or skin allodynia (severe pain from normally nonpainful stimuli, such as light touch); and autonomic neuropathy may produce diverse symptoms, depending on the affected glands and organs, but common symptoms are poor bladder control, abnormal blood pressure or heart rate, and reduced ability to sweat normally.[4][5][6]

Peripheral neuropathy may be classified according to the number and distribution of nerves affected (mononeuropathy, mononeuritis multiplex, or polyneuropathy), the type of nerve fiber predominantly affected (motor, sensory, autonomic), or the process affecting the nerves; e.g., inflammation (neuritis), compression (compression neuropathy), chemotherapy (chemotherapy-induced peripheral neuropathy).

Mononeuropathy is a type of neuropathy that only affects a single nerve.[8] Diagnostically, it is important to distinguish it from polyneuropathy because when a single nerve is affected, it is more likely to be due to localized trauma or infection.

The most common cause of mononeuropathy is physical compression of the nerve, known as compression neuropathy. Carpal tunnel syndrome and axillary nerve palsy are examples. Direct injury to a nerve, interruption of its blood supply resulting in (ischemia), or inflammation also may cause mononeuropathy.

"Polyneuropathy" is a pattern of nerve damage that is quite different from mononeuropathy, often more serious and affecting more areas of the body. The term "peripheral neuropathy" sometimes is used loosely to refer to polyneuropathy. In cases of polyneuropathy, many nerve cells in various parts of the body are affected, without regard to the nerve through which they pass; not all nerve cells are affected in any particular case. In distal axonopathy, one common pattern is that the cell bodies of neurons remain intact, but the axons are affected in proportion to their length; the longest axons are the most affected. Diabetic neuropathy is the most common cause of this pattern. In demyelinating polyneuropathies, the myelin sheath around axons is damaged, which affects the ability of the axons to conduct electrical impulses. The third and least common pattern affects the cell bodies of neurons directly. This usually picks out either the motor neurons (known as motor neuron disease) or the sensory neurons (known as sensory neuronopathy or dorsal root ganglionopathy).

The effect of this is to cause symptoms in more than one part of the body, often symmetrically on left and right sides. As for any neuropathy, the chief symptoms include motor symptoms such as weakness or clumsiness of movement; and sensory symptoms such as unusual or unpleasant sensations such as tingling or burning; reduced ability to feel sensations such as texture or temperature, and impaired balance when standing or walking. In many polyneuropathies, these symptoms occur first and most severely in the feet. Autonomic symptoms also may occur, such as dizziness on standing up, erectile dysfunction, and difficulty controlling urination.

Polyneuropathies usually are caused by processes that affect the body as a whole. Diabetes and impaired glucose tolerance are the most common causes. Hyperglycemia-induced formation of advanced glycation end products (AGEs) is related to diabetic neuropathy.[9] Other causes relate to the particular type of polyneuropathy, and there are many different causes of each type, including inflammatory diseases such as Lyme disease, vitamin deficiencies, blood disorders, and toxins (including alcohol and certain prescribed drugs).

Most types of polyneuropathy progress fairly slowly, over months or years, but rapidly progressive polyneuropathy also occurs. It is important to recognize that at one time it was thought that many of the cases of small fiber peripheral neuropathy with typical symptoms of tingling, pain, and loss of sensation in the feet and hands were due to glucose intolerance before a diagnosis of diabetes or pre-diabetes. However, in August 2015, the Mayo Clinic published a scientific study in the Journal of the Neurological Sciences showing "no significant increase in...symptoms...in the prediabetes group", and stated that "A search for alternate neuropathy causes is needed in patients with prediabetes." [10]

The treatment of polyneuropathies is aimed firstly at eliminating or controlling the cause, secondly at maintaining muscle strength and physical function, and thirdly at controlling symptoms such as neuropathic pain.

Mononeuritis multiplex, occasionally termed polyneuritis multiplex, is simultaneous or sequential involvement of individual noncontiguous nerve trunks,[11] either partially or completely, evolving over days to years and typically presenting with acute or subacute loss of sensory and motor function of individual nerves. The pattern of involvement is asymmetric, however, as the disease progresses, deficit(s) becomes more confluent and symmetrical, making it difficult to differentiate from polyneuropathy.[12] Therefore, attention to the pattern of early symptoms is important.

Mononeuritis multiplex also may cause pain, which is characterized as deep, aching pain that is worse at night and frequently in the lower back, hip, or leg. In people with diabetes mellitus, mononeuritis multiplex typically is encountered as acute, unilateral, and severe thigh pain followed by anterior muscle weakness and loss of knee reflex.[medical citation needed]

Electrodiagnostic medicine studies will show multifocal sensory motor axonal neuropathy.

It is caused by, or associated with, several medical conditions:

Autonomic neuropathy is a form of polyneuropathy that affects the non-voluntary, non-sensory nervous system (i.e., the autonomic nervous system), affecting mostly the internal organs such as the bladder muscles, the cardiovascular system, the digestive tract, and the genital organs. These nerves are not under a person's conscious control and function automatically. Autonomic nerve fibers form large collections in the thorax, abdomen, and pelvis outside the spinal cord. They have connections with the spinal cord and ultimately the brain, however. Most commonly autonomic neuropathy is seen in persons with long-standing diabetes mellitus type 1 and 2. In mostbut not allcases, autonomic neuropathy occurs alongside other forms of neuropathy, such as sensory neuropathy.

Autonomic neuropathy is one cause of malfunction of the autonomic nervous system, but not the only one; some conditions affecting the brain or spinal cord also may cause autonomic dysfunction, such as multiple system atrophy, and therefore, may cause similar symptoms to autonomic neuropathy.

The signs and symptoms of autonomic neuropathy include the following:

Neuritis is a general term for inflammation of a nerve[21] or the general inflammation of the peripheral nervous system. Symptoms depend on the nerves involved, but may include pain, paresthesia (pins-and-needles), paresis (weakness), hypoesthesia (numbness), anesthesia, paralysis, wasting, and disappearance of the reflexes.

Causes of neuritis include:

Types of neuritis include:

Those with diseases or dysfunctions of their nerves may present with problems in any of the normal nerve functions. Symptoms vary depending on the types of nerve fiber involved.[citation needed]In terms of sensory function, symptoms commonly include loss of function ("negative") symptoms, including numbness, tremor, impairment of balance, and gait abnormality.[24] Gain of function (positive) symptoms include tingling, pain, itching, crawling, and pins-and-needles. Motor symptoms include loss of function ("negative") symptoms of weakness, tiredness, muscle atrophy, and gait abnormalities; and gain of function ("positive") symptoms of cramps, and muscle twitch (fasciculations).[25]

In the most common form, length-dependent peripheral neuropathy, pain and parasthesia appears symmetrically and generally at the terminals of the longest nerves, which are in the lower legs and feet. Sensory symptoms generally develop before motor symptoms such as weakness. Length-dependent peripheral neuropathy symptoms make a slow ascent of leg, while symptoms may never appear in the upper limbs; if they do, it will be around the time that leg symptoms reach the knee.[26] When the nerves of the autonomic nervous system are affected, symptoms may include constipation, dry mouth, difficulty urinating, and dizziness when standing.[25]

The causes are grouped broadly as follows:

Peripheral neuropathy may first be considered when an individual reports symptoms of numbness, tingling, and pain in feet. After ruling out a lesion in the central nervous system as a cause, diagnosis may be made on the basis of symptoms, laboratory and additional testing, clinical history, and a detailed examination.

During physical examination, specifically a neurological examination, those with generalized peripheral neuropathies most commonly have distal sensory or motor and sensory loss, although those with a pathology (problem) of the nerves may be perfectly normal; may show proximal weakness, as in some inflammatory neuropathies, such as GuillainBarr syndrome; or may show focal sensory disturbance or weakness, such as in mononeuropathies. Classically, ankle jerk reflex is absent in peripheral neuropathy.

A physical examination will involve testing the deep ankle reflex as well as examining the feet for any ulceration. For large fiber neuropathy, an exam will usually show an abnormally decreased sensation to vibration, which is tested with a 128-Hz tuning fork, and decreased sensation of light touch when touched by a nylon monofilament.[26]

Diagnostic tests include electromyography (EMG) and nerve conduction studies (NCSs), which assess large myelinated nerve fibers.[26] Testing for small-fiber peripheral neuropathies often relates to the autonomic nervous system function of small thinly- and unmyelinated fibers. These tests include a sweat test and a tilt table test. Diagnosis of small fiber involvement in peripheral neuropathy may also involve a skin biopsy in which a 3mm-thick section of skin is removed from the calf by a punch biopsy, and is used to measure the skin intraepidermal nerve fiber density (IENFD), the density of nerves in the outer layer of the skin.[24] Reduced density of the small nerves in the epidermis supports a diagnosis of small-fiber peripheral neuropathy.

Laboratory tests include blood tests for vitamin B-12 levels, a complete blood count, measurement of thyroid stimulating hormone levels, a comprehensive metabolic panel screening for diabetes and pre-diabetes, and a serum immunofixation test, which tests for antibodies in the blood.[25]

The treatment of peripheral neuropathy varies based on the cause of the condition, and treating the underlying condition can aid in the management of neuropathy. When peripheral neuropathy results from diabetes mellitus or prediabetes, blood sugar management is key to treatment. In prediabetes in particular, strict blood sugar control can significantly alter the course of neuropathy.[24] In peripheral neuropathy that stems from immune-mediated diseases, the underlying condition is treated with intravenous immunoglobulin or steroids. When peripheral neuropathy results from vitamin deficiencies or other disorders, those are treated as well.[24]

A range of medications that act on the central nervous system has been found to be useful in managing neuropathic pain. Commonly used treatments include tricyclic antidepressants (such as nortriptyline or amitriptyline), the serotonin-norepinephrine reuptake inhibitor (SNRI) medication duloxetine, and antiepileptic therapies such as gabapentin, pregabalin, or sodium valproate. Few studies have examined whether nonsteroidal anti-inflammatory drugs are effective in treating peripheral neuropathy.[38]

Symptomatic relief for the pain of peripheral neuropathy may be obtained by application of topical capsaicin. Capsaicin is the factor that causes heat in chili peppers. The evidence suggesting that capsaicin applied to the skin reduces pain for peripheral neuropathy is of moderate to low quality and should be interpreted carefully before using this treatment option.[39] Local anesthesia often is used to counteract the initial discomfort of the capsaicin. Some current research in animal models has shown that depleting neurotrophin-3 may oppose the demyelination present in some peripheral neuropathies by increasing myelin formation.[40]

Evidence supports the use of cannabinoids for some forms of neuropathic pain.[41]

Transcutaneous electrical nerve stimulation therapy may be effective and safe in the treatment of diabetic peripheral neuropathy. A recent review of three trials involving 78 patients found some improvement in pain scores after 4 and 6, but not 12 weeks of treatment and an overall improvement in neuropathic symptoms at 12 weeks.[42] Another review of four trials found significant improvement in pain and overall symptoms, with 38% of patients in one trial becoming asymptomatic. The treatment remains effective even after prolonged use, but symptoms return to baseline within a month of cessation of treatment.[43]

Read more from the original source:

Peripheral neuropathy - Wikipedia

Read More...

Peripheral neuropathy – Symptoms and causes – Mayo Clinic

Monday, October 1st, 2018

Overview

Peripheral neuropathy, a result of damage to your peripheral nerves, often causes weakness, numbness and pain, usually in your hands and feet. It can also affect other areas of your body.

Your peripheral nervous system sends information from your brain and spinal cord (central nervous system) to the rest of your body. Peripheral neuropathy can result from traumatic injuries, infections, metabolic problems, inherited causes and exposure to toxins. One of the most common causes is diabetes mellitus.

People with peripheral neuropathy generally describe the pain as stabbing, burning or tingling. In many cases, symptoms improve, especially if caused by a treatable condition. Medications can reduce the pain of peripheral neuropathy.

Peripheral neuropathy care at Mayo Clinic

Every nerve in your peripheral system has a specific function, so symptoms depend on the type of nerves affected. Nerves are classified into:

Signs and symptoms of peripheral neuropathy might include:

If autonomic nerves are affected, signs and symptoms might include:

Peripheral neuropathy can affect one nerve (mononeuropathy), two or more nerves in different areas (multiple mononeuropathy) or many nerves (polyneuropathy). Carpal tunnel syndrome is an example of mononeuropathy. Most people with peripheral neuropathy have polyneuropathy.

Seek medical care right away if you notice unusual tingling, weakness or pain in your hands or feet. Early diagnosis and treatment offer the best chance for controlling your symptoms and preventing further damage to your peripheral nerves.

Not a single disease, peripheral neuropathy is nerve damage caused by a number of conditions. Causes of neuropathies include:

In a number of cases, no cause can be identified (idiopathic).

Peripheral neuropathy risk factors include:

Complications of peripheral neuropathy can include:

The best way to prevent peripheral neuropathy is to manage medical conditions that put you at risk, such as diabetes, alcoholism or rheumatoid arthritis.

For example:

Aug. 09, 2017

See more here:

Peripheral neuropathy - Symptoms and causes - Mayo Clinic

Read More...

Guidelines for Veterans Agent Orange and Peripheral …

Monday, October 1st, 2018

If you were on the ground in Vietnam the VA law now presumes you were exposed to Agent Orange/Toxic Herbicides, the VA law now recognizes that Agent Orange or Toxic Herbicidescause Chronic Peripheral Neuropathy (or any diagnosis related to PN) so you DO NOT HAVE TO PROVE this by VA law. The one trick the VA and IOM put in the new law is the requirement of EARLY ONSET and this is a bogus requirement. See more below on how to challenge this part of the law.

Here is how to work an application or appeal and the references that you should use in the appeal:

First, you will find all that you need to know in the Vietnam Veterans of America (VVA) bookletto submit an Agent Orange / Toxic Herbicidesclaim for yourself, or for surviving family members of deceased Vietnam veterans, or for biological children of Vietnam veterans born with certain birth defects (listed in the booklet), or for incarcerated Vietnam veterans and information on other benefits available to Vietnam veterans with Agent Orange or toxic herbicides related illnesses.

To print a copy of theVVAbooklet click on this title: The VVA Self Help Guideto Service Connected Disability Compensation for Exposure to Agent Orange: For Veterans and Their Families. Then in the RIGHT column, click on the booklet and print!

Next, we highly recommend that you find a Service Officer from the VVA. Enter youre STATE in the SEARCH form and it will list those for your entire State. Then select the one that is nearest to you.

Effective immediately in 2015there is a new way to file a claimaccording to the VA. Click on the link to see this information.

Direct Basis: If your illness is not listed in the VA list of presumptive illnesses, the law permits the veteran to establish proof of a direct connection between exposure to Agent Orange or Toxic Herbicides, symptoms of a chronic neuropathy, diagnosis and medical history by establishment of reasonable doubt and the principle of high probability, without early on-set.

This process just requires more documentation of the medical tests, diagnosis, and statements that all other causes of your illness have been ruled out and it is more likely than not due to exposure to toxic herbicides used during the Vietnam War. In our guidance on Chronic Peripheral Neuropathy, there are cases listed where this was accomplished to which you can refer and see the decision that was made and why.

In this process of a direct basis,the information on Affidavits andLegal Casesfor AO and Peripheral Neuropathy, prior to the rule of presumptioncould be helpful and you may find these in this booklet by clicking on the link.

FACTS ON AGENT ORANGE AND THE VA RECOGNITION OF CHRONIC PERIPHERAL NEUROPATHY.

For decades the VA with support from the Institute of Medicine denied that there could be chronic neuropathy from agent orange exposure. Then in 2010 after years of false claims the IOM acknowledge that they were wrong and the VA now recognizes Chronic PN from Agent Orange if you were on the ground in Vietnam with one catch which I will discuss below and how to defeat the VA on early onset.

Peripheral Neuropathy is now listed as presumptive to AO exposure see the ruling:

If your neuropathy is secondary to a VA recognized disease then you do not have to deal with the early onset requirement in VA law. Examples would be diabetes (Prediabetes is a recognized cause of neuropathy), cancer, treatments for cancer and so forth which the VA recognizes as due to Agent Orange exposure.These are common recognized conditions that cause chronic neuropathy. You can quote or refer to Dr. Norman Latovs book to show this as the case if needed. Norman Latov MD, PhD, Peripheral Neuropathy: When the Numbness, Weakness, and Pain Wont Stop, 2007 AAN Press

If the above is not the case, I would submit an appeal with the following statement in response to any legal claimby the VA.

NOTE: When you submit a statement to the VA it is wise to do so using the following statement at the end by your signature and then have it notarized:

I declare (or certify, verify, or state) under penalty of perjury that the foregoing is true and correct. Executed on (date). (Signature)

Peripheral Neuropathy is presumptively related to exposure to Agent Orange or toxic herbicides and no proof of this relationship as a cause is required by the current VA law. This is especially true when medicine is not able to establish another cause for the Neuropathy and often terms it idiopathic or of unknown cause. The VA law does require the early onset at 10% disabling levels within 1 year after exposure. However, please be advised that following the war the medical establishment did not have the clinical knowledge to diagnose, treat or even knowledge to recognize the symptoms of Peripheral Neuropathy in the 1960s, 70s let alone at the 10% disabling level. The symptoms were often misdiagnosed as symptoms of other medical issues or worse dismissed. Often medical personnel would report these symptoms as of no consequence while even failing to record them under the circumstances of the battlefield. Add to this the veterans desire to do nothing but return home, ignoring the symptoms.Little research was available regarding the effects of Agent Orange on veterans during their service. Furthermore, it is now know that the component of arsenic in Agent Blue used extensively during the Vietnam War following long term exposure will cause a delayed onset of a progressive chronic sensorimotor axonal polyneuropathy and therefore rules out any need for the early onset in the law since nothing has ever been evaluated given long term exposure to arsenic and the other compounds in the various components of Agent Orange. The following references support this statement.

Use the following references in YOUR APPEAL to support the above statement regarding early on-set.

1.No books for patient help to even recognize the symptoms of Peripheral Neuropathy, were available to the veterans until 2007: See: Norman Latov MD, PhD, Peripheral Neuropathy: When the Numbness, Weakness, and Pain Wont Stop, 2007 AAN Press AND the book reveals the difficulty in diagnosis in the years during and following the Vietnam War. Books on Peripheral Neuropathy

2.In 2012, Neurology struggles to diagnose Peripheral Neuropathy even in 2015: SEE: How to Diagnose Peripheral Neuropathy? No Simple Answers by Mark Moran, Neurology Today, March 15, 2012.

3. In 2001, Toxic Neuropathies were often dismissed by the principle that once removed from the toxin; the neuropathy resolved and did not become chronic! In 2010 the Institute of Medicine and the VA law recognized Agent Orange related toxic neuropathy years after exposure and this conclusion followed years of denial by the IOM and the VA. See: Peripheral Neuropathy: A Practical Approach to Diagnosis and Management by Dr. Didier Cross, M.D., Editor, 2001 and Chapter 21, page 387, Identification and Diagnosis of Toxic Polyneuropathies Dr. Alan Berger.

4. Thomas H. Brannagan, MD, Director, Neuropathy Center of Excellence, Columbia University, as quoted in the DVD production Coping with Chronic Neuropathy, 2010, (Lecture by LTC Eugene B Richardson, USA (Ret) who went for four decades before diagnosis and treatment with chronic neuropathy that has left him VA recognized 100% disabled due to Agent Orange exposure and Peripheral Neuropathy and a link to hisstory is listedin a following paragraph: One Mans Journey with Neuropathy) by the Network for Neuropathy Support, Inc., dba Neuropathy Support Network. For years medicine did not have the tools to diagnose or treat Neuropathy and the patient was left on their own Note: Today this DVD is endorsed by leading Neuromuscular Neurologists in the field of Peripheral Neuropathy, Psychiatrists, Psychologists, Nurses, Dermatologists, Retired General Officers, other senior officers of the U.S. Army and other medical professionals as well as by patients worldwide who are just now beginning to grasp the clinical aspects of Peripheral Neuropathy.

5. In December 2002, in the Neurology 59 (Supplement 6), Norman Latov, MD, PhD, et el, published a document regarding the difficulties in the diagnosis and treatment of immune-mediated neuropathies, titled Advances in the diagnosis and treatment of CIDP and related immune-mediated neuropathies.

6. The Journal of the Peripheral Nervous System the official Journal of the Peripheral Nerve Society, Volume 17, Supplement 2, May 2012, editor David R. Cornblath of John Hopkins University School of Medicine, Baltimore, MD, in the various scientific articles notes not only the current research that is being done, but the lack of the medical establishments ability to diagnose and treat many of the chronic neuropathies even in 2012 let alone in 1960 and 1970. Dr. Thomas H. Brannagan III of Columbia University, College of Physicians and Surgeons, New York, NY, states in the opening article, Many patients are not aware of their diagnosis, are not given the diagnosis or (are) treated, or the diagnosis is delayed and this is in 2012! Currently, the only treatments available for neuropathy are aimed at treating the underlying medical conditions that cause the neuropathy or treating symptoms such as pain. Neither treats the actual nerve fiber dysfunction or fiber loss or helps nerve fibers regenerate.Continued research into the underlying mechanisms of neuropathyare needed to address this unmet medical need among patients with neuropathy and again this is the science in 2012 not 1960 and 1970 when no tools existed to diagnose the patients neuropathy let alone clinical knowledge to recognize the many symptoms of neuropathy following exposure to Agent Orange.

7. Louis Weimer, MD, recorded on DVD, A lecture on Autonomic Neuropathy Under Recognized Syndrome, January 17, 2001

8. In the Textbook of Peripheral Neuropathy by Peter D. Donofrio, M.D., published by DEMOS Medical, 2012 (numerous other authors contributing to the work) (Professor of Neurology, Chief of the Neuromuscular Section, Vanderbilt University Medical Center, Nashville, TN), notes that acute arsenic exposure is associated with sensorimotor axonal polyneuropathy see pages 89-91 in the text article Occupational, Biologic, and Environmental Toxic Neuropathies by James W Albers, M.D. PhD, Emeritus Professor of Neurology, University of Michigan Health System, Ann Arbor, Michigan, for full description of symptoms and treatments. Arsenic in what was called Agent Blue was used to destroy the food supplies throughout Vietnam from 1962 to 1971. The use of arsenic was not condemned for use by the FDA until 2011 when a peer-evaluated study was completed and 89 forms of arsenic out of 102 compounds were removed from the market because they convert from organic to inorganic arsenic. Bottom line, arsenic is a heavy metal, like lead, and all heavy metals are dangerous and carcinogenic causing Chronic Peripheral Neuropathy along with other damage to the human body. To read the dangers and damages done by arsenic in Agent Blue along with the many warnings that were ignored by those responsible, see the article Agent Blue by Loana Hoyman in the May/June 2015 issue, Volume 35. No. 3, of the Vietnam Veterans of America publication.

9. Arsenic in the Environment: Blue by Loana Hoylman published in VVA Veteran (Vietnam Veterans of America) July/August 2015 Vol 35, No. 4 notes that the World Health Organization said in 2012 that Arsenic contaminated water is the greatest threat to health in the world reporting that Arsenic is a known neurotoxin. Arsenic was the main component in Agent Blue used in Vietnam. The use of Arsenic in agricultural use was banned in 1980 with more stringent ban confirmed in 2014 when evidence of environmental poisoning was confirmed. While we are all exposed to Arsenic, Vietnam Veterans for a year or more were exposed to Agent Blue and are at the highest risk for the cumulative effects of Arsenic from food and water. The problem with arsenic is that it stays in the (human) system. It accumulates in the body as one consumes contaminated food and comes in contact with a contaminated environment especially if exposure is over a long period of time such as was true for the veteran of Vietnam.

10. In 2003 FOCAL PERIPHERAL NEUROPATHIES by Geraint Fuller: See J Neurol Neurosurg Psychiatry 2003;74:ii20-ii24 doi:10.1136/jnnp.74.suppl_2.ii20 Dr GN Fuller, Department of Neurology, Gloucester Royal Hospital, Great Western Road, Gloucester GL1 3NN, UK; geraint@Fullerg.demon.co.uk focal peripheral neuropathiesFocal peripheral neuropathies are not at the fashionable end of the neurological street. However they are important, as they are very common, sometimes disabling, and often treatable. They can also be a source of confusion when they occur in patients with other neurological diseases. The management of focal peripheral neuropathies is based on certain general principles with a relatively limited backing from clinical trials. These principles relate to understanding the:

11. VA: Presumptive Service Connection and Disability Compensation, November 18, 2014 7-5700 R41405. This Congressional Service Report shows clearly the serious problems of historical fact in the early onset rule in VA law specifically for Peripheral Neuropathy.This requirement is a bogus requirement that stands in the face of facts, not the least of which is that the medical establishment, during the years of and following the Vietnam War, could not recognize the symptoms of peripheral neuropathy let alone at the 10% disabling level as required by VA law since 2010. This document shows clearly that there was no medical basis to make a determination as to early onset retroactive to the period of the Vietnam War, as to making any sound conclusions, establishing standards, diagnostic codes, disability determinations or for establishing an absolute mandatory time specific criteria for symptoms or a diagnosis for Peripheral Neuropathy, due to exposure to Agent Orange/Agent Blue and other toxins in the decade of and for many years following the Vietnam War.

12. Include these statements witha copy of the document One Mans Journey with Neuropathy showing by clear examplethe bogus nature of the early onset requirement.

In 2013 the VA began recognizing that exposure to Agent Orange (AO) causes Chronic Peripheral Neuropathy. However the Institute of Medicine (IOM)added a requirement of early on-set to connect the condition with AO exposure. Yet during the decades of the Vietnam War and after,even to the current year, clinical diagnosis and recognition of the symptoms of PN are just now being recognizedand diagnosis and treatmentremain difficult.

For decades with the symptoms of chronic neuropathy clearly recorded in LTC Richardsons medical records, the VA denied all of this information for six years. The VA reviewers did this out of ignorance of both the symptoms of PN and the difficulty of diagnosis by noting that the symptoms, while clearly in his medical records, by blaming the symptoms on other medical conditions.

Then after his Neuromuscular Neurologist submitted the facts from his service medical records, the VA reviewers lied four times about the clear statements in his medical records stating that these facts were not in his medical records.

Over six years later the VA is still delaying his request for a hearing on these issues, so that his claim is retroactive to his first submission of his original application and the fact that all the information in regards to these issues are included in his original submission.

(Attach a copy of this career officers story (One Mans Journey with Neuropathy) to your submission as it shows the bogus nature of the early onset requirement.)

The experience of LTC Eugene B Richardson, USA (Retired) with currently 100% VA disability due to Chronic Neuropathy after service in Vietnam in 1967-68 is told in this story and shows the lack of medical science and limits of medicine in general to recognize the symptoms of neuropathy and to diagnose neuropathy, let alone at the 10% level of disability.

Helpful Doctors Statement: A statement from a doctor to the effect that given that chronic peripheral neuropathy is now recognized as presumptive to exposure to Agent Orange or toxic herbicides by the VA and given that all other causes of the patients neuropathy have been ruled out by testing, it is likely greater than a 50% probability that the patients peripheral neuropathy is more likely than not due to exposure to Agent Orange and toxic herbicides.

10. Board of Veterans Appeals cases:

Make reference to these legal cases where limited information was used to prove the veterans cases on a DIRECT basis before the VA changed the law to recognize Chronic Peripheral Neuropathy:a. Citation Nr. 0606156 03/03/06 Docket No. 04-19 301 On Appeal from the Department of Veterans Affairs Regional Office in Phoenix, Arizona

b. Citation Nr. 0802669 01/24/08 Docket No. 97-33 277 On Appeal from the Department of Veterans Affairs Regional Office in Atlanta, Georgia

c. Citation Nr. 0306225 04/01/03 Docket No. 97-18 169 On Appeal from the Department of Veterans Affairs Regional Office in Milwaukee, Wisconsin

d. Citation Nr. 0821251 06/27/08 Docket No. 05-17 482 On Appeal from the Department of Veterans Affairs Regional Office in Nashville, Tennessee

APPENDEX

COPIES OF SUCCESSFUL LEGAL CASES (Symptoms developed after the one year presumptive period)

1. Case from Phoenix, Arizona

Citation Nr: 0606156 Decision Date: 03/03/06 Archive Date: 03/14/06

(DOCKET NO. 04-19 301) DATE On appeal from the Department of Veterans Affairs Regional Office in Phoenix, Arizona

THE ISSUES

1. Entitlement to service connection for peripheral neuropathy of both lower extremities, claimed as nerve damage to the legs and feet and also as circulatory damage to the feet as due to Agent Orange.

2. Entitlement to service connection for skin cancer, claimed as spots on the face, arms, and hands that tingle and also as nerve damage.

REPRESENTATION

Veteran represented by: Arizona Veterans Service Commission

WITNESS AT HEARING ON APPEAL

Veteran ATTORNEY FOR THE BOARD

J.W. Kim, Associate Counsel

INTRODUCTION

The veteran served on active duty from March 1963 to March 1966, including service in the Republic of Vietnam.

These matters come before the Board of Veterans Appeals (Board) on appeal of rating decisions by the Department of Veterans Affairs (VA) Regional Office (RO) in Phoenix, Arizona. In a January 2003 rating decision, the RO denied service connection for peripheral neuropathy of the left and right lower extremities. In a December 2003 rating decision, the RO continued the prior denials of service connection for peripheral neuropathy and denied service connection for skin cancer, claimed as spots on the face, arms, and hands that tingle and also as nerve damage. The veteran timely perfected an appeal of these determinations to the Board. In September 2005, the veteran testified before the undersigned Veterans Law Judge at a Board hearing at the RO.

The issue of service connection for skin cancer, claimed as spots on the face, arms, and hands that tingle and also as nerve damage, is addressed in the REMAND portion of the decision below and is REMANDED to the RO via the Appeals Management Center (AMC), in Washington, DC.

FINDINGS OF FACT

Resolving all reasonable doubt in favor of the veteran, peripheral neuropathy of both lower extremities is related to service, specifically to exposure to Agent Orange.

CONCLUSION OF LAW

Peripheral neuropathy of both lower extremities was incurred in active service. 38 U.S.C.A. 1101, 1110, 1112, 1113,1116, 5107 (West 2002); 38 C.F.R. 3.102, 3.303, 3.307,3.309 (2005).

REASONS AND BASES FOR FINDINGS AND CONCLUSION

Initially, the Board finds that the agency of original jurisdiction has substantially satisfied the duties to notify and assist, as required by the Veterans Claims Assistance Act of 2000. 38 U.S.C.A. 5100, 5102, 5103, 5103A, 5107, 5126 (West 2002 & Supp. 2005); 38 C.F.R. 3.102, 3.156(a), 3.159 and 3.326(a) (2005).

To the extent that there may be any deficiency of notice or assistance, there is no prejudice to the veteran in proceeding with this case given the favorable nature of the Boards decision. Service connection may be granted for disability resulting from disease or injury incurred in or aggravated by service. 38 U.S.C.A. 1110 (West 2002); 38 C.F.R. 3.303(a) (2005).

Service connection may also be awarded for a chronic condition when: (1) a chronic disease manifests itself and is identified as such in service (or within the presumptive period under 38 C.F.R. 3.307) and the veteran presently has the same condition; or (2) a chronic disease manifests itself during service (or within the presumptive period) but is not identified until later and there is a showing of continuity of symptomatology after discharge. 38 C.F.R. 3.303(b) (2005); see 38 C.F.R. 3.307, 3.309 (2005).

A veteran who, during active military, naval, or air service, served in the Republic of Vietnam during the Vietnam era, and has a disease listed at 38 C.F.R. 3.309(e), shall be presumed to have been exposed during such service to an herbicide agent, unless there is affirmative evidence to establish that the veteran was not exposed to any such agent during that service. 38 C.F.R. 3.307(a)(6)(iii).

If a veteran was exposed to an herbicide agent during active military, naval, or air service, the following diseases shall be service connected if the requirements of 38 C.F.R. 3.307(a)(6)(iii) are met, even though there is no record of such disease during service, provided further that the rebuttable presumption provisions of 38 C.F.R. 3.307(d) are also satisfied: Chloracne or other acne form disease consistent with Chloracne; Type II Diabetes; Hodgkins disease; multiple myeloma; non-Hodgkins lymphoma; acute and sub-acute peripheral neuropathy; porphyria cutanea tarda; prostate cancer; respiratory cancers (cancer of the lung, bronchus, larynx or trachea); and soft-tissue sarcoma (other than osteosarcoma, chondrosarcoma, Kaposis sarcoma, or mesothelioma). 38 C.F.R. 3.309(e); 66 Fed. Reg. 23,166, 23,168-69 (May 8, 2001)

The term acute and sub-acute peripheral neuropathy means transient peripheral neuropathy that appears within weeks or months of exposure to an herbicide agent and resolves within two years of the date of onset. Note 2, 38 C.F.R. 3.309(e).

The veteran contends, in essence, that he has peripheral neuropathy of both lower extremities due to exposure to Agent Orange during service. He asserts that symptoms developed in approximately 1970 and that they have gradually become worse, but that he did not seek treatment until April 2002.

The record shows that the veteran served in the Republic of Vietnam during the Vietnam era. Thus, exposure to Agent Orange is presumed. 38 C.F.R. 3.307(a)(6)(iii). Initially, the Board notes that only acute and sub-acute peripheral neuropathy are recognized by VA as diseases associated with exposure to Agent Orange. 38 C.F.R. 3.309(e).

In this regard, the record shows that the veteran does not have acute or sub-acute peripheral neuropathy as defined by VA regulations. The fact that the veteran is not entitled to the foregoing regulatory presumption of service connection does not preclude an evaluation as to whether he is entitled to service connection on a direct basis or entitled to presumptive service connection for a chronic disease. See Combee v. Brown, 34 F.3d 1039 (Fed. Cir. 1994).

After review, the Board notes a December 2002 VA neurological disorders examination report and a July 2003 letter from Dr. Durham, the veterans private treating physician.

The VA examination report reflects the examiners difficulty in determining the etiology of the veterans peripheral neuropathy. The examiner stated that there is no clear cut evidence that exposure to herbicides caused the veterans peripheral neuropathy and acknowledged the discomfort of defining the veterans disorder as a neuropathy of unknown etiology. The examiner explained that unfortunately many peripheral neuropathies are of unknown etiology and to arbitrarily assign one to a caustic agent does not seem to be the best medical decision.

Dr. Durham begins his letter by noting that he has taken several comprehensive histories from the veteran and can find no other type of exposures either personal or industrial that could potentially account for the veterans neuropathy. He also noted reviewing the veterans VA medical records, including the above examination report, his own medical records, VAs Guide on Agent Orange Claims, and the veterans rating decision. Dr. Durham acknowledged that the veterans claim was denied because he did not complain of symptoms within the very short time period cited by VA after exposure to herbicides. He stated that it is clearly documented in the medical literature that neuropathy can be latent for a period of up to decades, and a denial based on short term exposure and short term initiation of acute complaints seems to be somewhat arbitrary. He opined that, given that the veteran does not have any evidence of any of the other major problems with which neuropathy is often associated, there is at least a 51 percent probability that the veterans neuropathy may be directly linked to exposure to dioxin/Agent Orange.

The Board acknowledges that the veterans claims file was not made available to Dr. Durham. The Board observes that review of the claims file is only required where necessary to ensure a fully informed examination or to provide an adequate basis for the examiners findings and conclusions. See VAOPGCPREC 20-95; 61 Fed. Reg. 10,064 (1996).

In this case, the Board finds that resort to the veterans claims file was not necessary because the veteran provided an accurate account of his medical history, thus ensuring a fully informed examination. In this regard, the Board observes that the veterans account as related to Dr. Durham essentially reflected the evidence of record at that time.

Further, Dr. Durham did review several pertinent documents, including the VA examination report. Given the above, and resolving all reasonable doubt in favor of the veteran, the Board finds that the veterans peripheral neuropathy of both lower extremities is due to his exposure to Agent Orange during service.

ORDER

Service connection for peripheral neuropathy of both lower extremities is granted.

2. Case from Atlanta, Georgia.

Citation Nr: 0802669

Decision Date: 01/24/08 Archive Date: 01/30/08

(DOCKET NO. 97-33 277 ) DATE On appeal from the Department of Veterans Affairs Regional Office in Atlanta, Georgia

THE ISSUE

Entitlement to service connection for peripheral neuropathy, to include on a direct basis and as secondary

to Agent Orange Exposure.

REPRESENTATION

Appellant represented by: Georgia Department of Veterans Services

WITNESSES AT HEARING ON APPEAL

Appellant and his spouse

ATTORNEY FOR THE BOARD

Tzu Wang, Associate Counsel

INTRODUCTION

The veteran served on active duty from July 1948 to August 1969. He served in the Republic of Vietnam from September 4,1967 to September 4, 1968.

This matter initially came before the Board of Veterans Appeals (Board) from a January 1997 rating decision of the Department of Veterans Affairs (VA) Regional Office (RO) in Atlanta, Georgia. In January 1998, the appellant and his spouse testified at the RO before a Decision Review Officer; a copy of the transcript has been associated with the claims file.

Subsequently, in December 1998 and August 2003, the Board remanded this case to the RO for further evidentiary development. In September 2007, the Board referred this case to the VAs Veterans Health Administration (VHA) for a medical opinion. The specialists opinion, dated October 18,2007, has been associated with the claims folder and, as required by law and regulation, the Board provided the appellant and his representative copies of this opinion and afforded them time to respond with additional evidence or argument. 38 C.F.R. 20.903(a) (2007). The case is now before the Board for further appellate consideration.

FINDING OF FACT

View post:

Guidelines for Veterans Agent Orange and Peripheral ...

Read More...

CBD and Neuropathy: Almost Magical Pain Relief Benefits

Monday, October 1st, 2018

This post was last updated on 9/10/2018.

Burning fingertips, sensations of walking on glass, and sleepless nights. Living with neuropathic pain is no way to live at all.

Yet thousands of people like you and me have to deal with, largely unpredictable, bursts of pain.

Youre not alone if you feel like your whole life is governed by pain. This post will give a brief overview of the prevalence of this class of pain as well as the causes before going into the evidence indicating the cannabinoid CBD can be effective in treating neuropathic pain of all kinds and causes.

After that, well talk about how to use CBD oil for neuropathic pain, as well as other product options (including which products to pick and where to get them). But first lets get a lay of the land.

Chronic pain has become an epidemic, especially as the Boomer generation approaches old age. For example, in Europe, chronic pain effects 1 in 4 elderly people.3

In Australia, this epidemic is of massive proportions, extending to over half of the elderly population, and as high as 80% of patients in nursing homes.4

In the US, responses to an ABC News poll indicate that as many as 38 million adults in the US deal with chronic pain on a daily basis, and as many as 12 million US citizens have used cannabis to help alleviate this pain.

To this point, the available medications for attempting to treat this pain are limited to anti-steroidals, opiates, and anti-depressants all hardcore drugs with harsh side effects of their own, and limited effectiveness. Its almost as though the patient is trading a half-cure for being put on even more drugs to deal with the debilitating side effects. My opinion here, but this system seems broken.

Peripheral neuropathy has many causes. At its core, it is nerve damage due to either chronic inflammation in the body or sudden trauma. Inflammation is your bodys natural response triggered by incoming stimuli that is perceived to be a threat to your body.

Neuropathy symptoms can arise due to inflammation related to:

These are just a few of many potential causes of neuropathy, albeit the most statistically common.

An oromucosal spray named Sativex was approved back in 2005 by the Canadian government for use in treating neuropathy.5 While Sativex itself is a brand name and must be obtained with a prescription, the important thing to note is that it is essentially just a combination of THC and CBD, cannabidiol, not much different than just using a full spectrum hemp extract in combination with THC.

Lets be real: it literally is just a full spectrum cannabis extract, extracted with ethanol, packaged up and branded by GW Pharmaceuticals. This is something you could buy yourself.

Sativex (THC + CBD) was found in multiple clinical trials to be extremely effective in controlling neuropathy pain in MS patients, as well as arthritis. It was later approved by the United States FDA in 2006 for trials to control cancer related neuropathy.

Historically, and quite ironically, Western understanding of the biological underpinnings of the pain system in the body was originally glimpsed through the lens of studying the plants cannabis, opium poppies, willow bark, and chile peppers. Out of the study of these plants and the naturally effective medicine inherent in them pharmaceutical companies formulated synthetic, highly addictive, drugs such as morphine, codeine, oxycontin.

Due to lack of commercial feasibility and patentability, pharmaceutical companies before the early 2000s hadnt made any endocannabinoid drug-derivatives.6Cannabinoids, however, are very well known for their analgesic effect in controlling pain in humans.7 Ask any anesthesiologist and they will agree, activation of the CB1 receptor (cannabinoid receptor 1) will lead to almost immediate alleviation of pain and inflammation.8 This pain reduction can be seen in fibromyalgia patients when treated with cannabis910 and even in cases of intestinal pain with IBS.

Cannabinoids like CBD have been shown to alleviate this pain by also activating glycine receptors.11

This study found some really convincing evidence for this neuropathic pain control in rats.12 According to the researchers,

The non-psychoactive compound, cannabidiol, or CBD, is the only component present at a high level in the extract able to bind to this receptor: thus cannabidiol was the compound responsible for the antinociceptive behavior observed.

A recent review by Dr. Igor Grant, director of the Center for Medicinal Cannabis Research at the University of California compared the effectiveness of cannabis against tricyclic antidepressants, gabapentin, anticonvulsants, and selective serotonin reuptake inhibitors. Cannabis was more effective than all except tricyclics at reducing neuropathy. 11

Cannabis as a treatment of neuropathic painis one of the topics with the most substantive collection of studies in the medical literature behind it.12This study also goes through the effective cannabinoids for neuropathic pain.12 And now, according to some researchers, cannabinoids hold the most potential for providing relief for thousands of sufferers, since nearly all pharmaceutical treatments fall short and have lead researchers to conclude that pharma treatment options for neuropathic pain have limited efficacy and use is fraught with dose dependent adverse effects.2

Due to Western medicines inability to formulate an effective treatment for neuropathy, many neuropathy sufferers are understandably turning tocannabis, namely hemps cannabidiol, as an alternative for pain management.

For a detailed guide about treating neuropathy with CBD, the kinds if neuropathy you may be experiencing, and recommended products shown to work against neuropathy for readers in the past, see our Neuropathy page.

In conclusion, CBD oil looks really promising for nerve painand neuropathy patients. CBD is probably good alternative treatment for neuropathic pain. CBD may have the ability to lower pain which is linked to its potent effect as an antioxidant and ability to lower inflammation significantly, and quickly. In fact, when put head to head against the other well-known antioxidants alpha-tocopherol(Vitamin E) and ascorbate (Vitamin C), cannabidiol beat out both of them in effectiveness with regards to lowering glutamate toxicity in neurons.1

What have you got to lose? This also comes after a careful analysis of the clinical trials of Sativex, which just appears to be a full spectrum cannabis extract similar to the ones found on this page, in combination with THC.

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

See the article here:

CBD and Neuropathy: Almost Magical Pain Relief Benefits

Read More...

Page 22«..10..19202122


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick